How to Prevent a Blood Clot - heartdisease - Health.com
Links shared publicly online about this topic.
- 248total visits
How to Prevent a Blood Clot - heartdisease - Health.com
View full resource at health.com
Tags: Circulation, Thrombotic Event, Blood Clot
Most Recently Shared on June 2, 2011 at 7:15 pm By:
How to prevent a blood clot: http://bit.ly/lPT1GG
Man critically ill in Bangkok flat after hospital kicks him out - Northern Ireland, Local & National - Belfasttelegraph.co.uk
belfasttelegraph.co.uk — “A west Belfast man who travelled to Thailand to visit his son in March remains ‘gravely ill’ his son told the Andersonstown News, after a blood clot on his brain was left untreated because the man and his family could not foot an £8,500 bill for a blood transfusion.” View full resource at belfasttelegraph.co.uk
Most Recently Shared on April 20, 2012 at 4:04 pm By:
ben goldacre Doctor, Psychiatrist, and Physician
People have no idea how expensive healthcare is, and how weird it is to have an NHS RT @AlvinDayman: http://t.co/rgy4d3UI
Dentist Pasadena CA | Dental Plaque and Blood Clots | Pasadena Laser Dentistry
pasadenalaserdentistry.com — “We have known for a long time that proper dental care prevents heart attacks, but now scientists are discovering that it could also prevent blood clots and life-threatening endocarditis.” View full resource at pasadenalaserdentistry.com
Most Recently Shared on April 10, 2012 at 4:15 pm By:
H. Robert Stender Doctor and Dentist
Here's another reason why you need to schedule your next dental appointment pronto --> http://t.co/ZiZn7Kub
J&J drug shines in trial against standard lung-clot drugs | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for” View full resource at reuters.com
Most Recently Shared on March 26, 2012 at 9:16 pm By:
ASH Health Organization and Hematology
J&J drug shines in trial against standard lung-clot drugs http://t.co/nP63qmta via @reuters
J&J drug shines in trial against standard lung-clot drugs
health.yahoo.net — “CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for it to become the eventual preferred treatment for the third most common cause of deaths in h.” View full resource at health.yahoo.net
Most Recently Shared on March 26, 2012 at 2:50 pm By:
Jane Anderson Healthy Eating Advisor
J&J drug shines in trial against standard lung-clot drugs http://t.co/288cvE0l
J&J drug shines in trial against standard lung-clot drugs - Yahoo! News
news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for it to become the eventual preferred treatment for the third most common cause of deaths in hospitals. ...” View full resource at news.yahoo.com
Most Recently Shared on March 26, 2012 at 2:48 pm By:
HealthTrendster Health Executive
J&J drug shines in trial against standard lung-clot drugs - CHICAGO (Reuters) - Johnson & Johnson's blood clot preve... http://t.co/wf9CH1yx
J&J drug shines in trial against standard lung-clot drugs - Yahoo! News
news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for it to become the eventual preferred treatment for the third most common cause of deaths in hospitals. ...” View full resource at news.yahoo.com
Most Recently Shared on March 26, 2012 at 1:33 pm By:
J&J drug shines in trial against standard lung-clot drugs: CHICAGO (Reuters) - Johnson & Johnson's blood clot pr... http://t.co/SnaALqXK
J&J drug shines in trial against standard lung-clot drugs | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for” View full resource at reuters.com
Most Recently Shared on March 26, 2012 at 1:31 pm By:
J&J drug shines in trial against standard lung-clot drugs: CHICAGO (Reuters) - Johnson & Johnson's... http://t.co/DczfFnLw #health #news
J&J drug shines in trial against standard lung-clot drugs | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for” View full resource at reuters.com
Most Recently Shared on March 26, 2012 at 1:20 pm By:
J&J drug shines in trial against standard lung-clot drugs http://t.co/keaagJjU
J&J drug shines in trial against standard lung-clot drugs | Reuters
reuters.com — “CHICAGO (Reuters) - Johnson & Johnson's blood clot preventer Xarelto proved as effective as and safer than standard treatments against blood clots of the lung in a big study, possibly paving the way for” View full resource at reuters.com
Most Recently Shared on March 26, 2012 at 1:20 pm By:
J&J drug shines in trial against standard lung-clot drugs http://t.co/oH80H0Yu
Merck blood clot drug in limbo after mixed results - chicagotribune.com
chicagotribune.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators, researchers said on Saturday.” View full resource at chicagotribune.com
Most Recently Shared on March 24, 2012 at 7:25 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Merck blood clot drug in limbo after mixed results - Chicago Tribune http://t.co/WRT7sDEK #health
Myshkin Ingawale: A blood test without bleeding | Video on TED.com
ted.com — “TED Talks Anemia is a major -- and completely preventable -- cause of deaths in childbirth in many places around the world, but the standard test is invasive and slow. In this witty and inspiring talk, TED Fellow Myshkin Ingawale describes how (after 32 tries) he and his team created a simple, portable, low-cost device that can test for anemia without breaking the skin.” View full resource at ted.com
Most Recently Shared on March 24, 2012 at 4:33 pm By:
Pauline Sweetman Health IT and Pharmacist
RT @adarsh: Myshkin Ingawale: A blood test without bleeding : http://t.co/ZQk5RZvC Small device, massive repercussions to come.
Merck blood clot drug in limbo after mixed results - Yahoo! News
news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators. Vorapaxar has been dogged by bleeding concerns since January 2011, when a safety committee overseeing the 26,449-patient study said the new type o” View full resource at news.yahoo.com
Most Recently Shared on March 24, 2012 at 3:52 pm By:
Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but worrisome bleedi... http://t.co/V3CP4aUx
Merck blood clot drug in limbo after mixed results
health.yahoo.net — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether the company will seek approval of the drug and whether.” View full resource at health.yahoo.net
Most Recently Shared on March 24, 2012 at 3:40 pm By:
Merck blood clot drug in limbo after mixed results http://t.co/UqbEmDsV
Merck blood clot drug in limbo after mixed results - Yahoo! News
news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators, researchers said on Saturday. Vorapaxar has been dogged by bleeding concerns since January 2011, when a safety committee overseeing the 26,449-patient study said the new type o” View full resource at news.yahoo.com
Most Recently Shared on March 24, 2012 at 2:34 pm By:
HealthTrendster Health Executive
Merck blood clot drug in limbo after mixed results - CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding ... http://t.co/CSjRsD5J
Merck blood clot drug in limbo after mixed results | Reuters
reuters.com — “CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions” View full resource at reuters.com
Most Recently Shared on March 24, 2012 at 2:30 pm By:
Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but wo... http://t.co/D7llHBd9 #health #news
Advertisement
